Poster Session 1

Presentations

P1.001

The obligation on UK transplant nurses to report reasonable suspicion of a transplant abuse abroad

David Matas (CA)

Bio Abstract

P1.003

A hospital-at-home model for early supported discharge in kidney transplant recipients: A four-year experience

Jia Ying Janelle Ngew (SG)

Bio Abstract

P1.004

Kerala’s Organ Transplantation Program: Design, Performance, and Implementation Barriers

Noble Gracious (IN)

Bio Abstract

P1.005

A separate organ donation unit could offer better economic value compared to a dialysis centre - A case study from an LMIC without Universal Health Care

Noble Gracious (IN)

Bio Abstract

P1.006

Indian Society of Organ Transplantation (ISOT) Position Statement on Immunological Evaluation in Kidney Transplantation

Pranjal Kashiv (IN)

Bio Abstract

P1.007

Pills, plans and priorities: Understanding medication history and future education needs in kidney transplant recipients

Sadia Jahan (AU)

Bio Abstract

P1.008

Mediators of graft survival disparities between Māori and non-Māori, non-Pasifika kidney transplant recipients

Thida Maung Myint (AU)

Bio Abstract

P1.009

From risk mapping to prevention: implementing Healthcare Failure Mode and Effect Analysis (HFMEA) in the organ donation and transplant process

Victor Cruz (BR)

Bio Abstract

P1.010

Fabry disease and kidney transplantation - facing the challenge

Lea Katalinic (HR)

Bio Abstract

P1.013

The lived experience of organ and tissue donation after assisted dying in New Zealand

Jo Ritchie (NZ)

Bio Abstract

P1.014

Potential for Uncontrolled Donation After Circulatory Death (Maastricht IIb) Following In-Hospital Cardiorespiratory Arrest in a High-Complexity Acute Care Hospital

Marc Bohils (ES)

Bio Abstract

P1.015

Short-term and long-term outcomes in living liver donors: A single center experience from Iran

Parisa Keshani (IR)

Bio Abstract

P1.016

🎗Average number of organs transplanted per donor, an useful tool for assessing the current trends in donation and transplantation in Colombia

William Cruz (CO)

Bio Abstract

P1.017

Effects of immunonutrition in renal transplant recipients: A systematic review and meta-analysis of randomised controlled trials

Michael Wong (GB)

Bio Abstract

P1.018

The impact of comprehensive nutrition counseling on metabolic and renal outcomes in early post-kidney transplant recipients

Nisarat Rungsawang (TH)

Bio Abstract

P1.020

A patient-centered framework for transplant care: integrating psychosocial health, lived experience, and long-term outcomes

Amber Carrier (US)

Bio Abstract

P1.022

“I was told not to bother having children because it was too complicated”. 10 tips for support women with a kidney transplant through pregnancy.

Brooke Huuskes (AU)

Bio Abstract

P1.023

Recognising and celebrating donor families:Co-created artwork through sustained meaningful engagement and involvement.

Jonathan Bannard-Smith (GB)

Bio Abstract

P1.024

From talk to action: Motivational interviewing to improve kidney transplant health literacy

Margaret Coakley (US)

Bio Abstract

P1.025

Psychosocial risk profiles and alcohol, nicotine and drug use in lung transplant candidates: A single-center study using the stanford integrated psychosocial assessment for transplant

Aleksandra Stańska (PL)

Bio Abstract

P1.026

Beyond gatekeeping: Stanford integrated psychosocial assessment for transplant as a guide to psychosocial prehabilitation in a single-center cohort of lung transplant candidates

Aleksandra Stańska (PL)

Bio Abstract

P1.027

Assessing scenarios that influence living donation

Camilla Nonterah (US)

Bio Abstract

P1.028

Developing a person-centered integrated care model in living kidney donation linking primary and tertiary care: a qualitative study using a sequential participatory approach

Chloe Wong-Mersereau (CA)

Bio Abstract

P1.029

Turning Loss into Legacy: The success of organ donation in the United Arab Emirates

Ananthanayagi Purushothaman (AE)

Bio Abstract

P1.033

Advancing organ donation under the belt & road international cooperation: The formulation, content, and implementation of the Guangzhou initiative

Jie Zhao (CN)

Bio Abstract

Presentations

P1.040

Patient-reported measures in children and adolescents with chronic kidney disease and their validation: A scoping review

Angela Rejuso (AU)

Bio Abstract

P1.041

Process evaluation of the NAVKIDS2 patient navigation intervention for children with chronic kidney disease: a mixed method study

Chandana Guha (AU)

Bio Abstract

P1.042

Importance of long-term social outcomes on graft functions after pediatric kidney transplantation

Esra Baskin (TR)

Bio Abstract

P1.043

Outcomes and Safety of Therapeutic Plasma Exchange in Pediatric Transplant and Organ Failure: A Retrospective Observational Study

Esra Baskin (TR)

Bio Abstract

P1.044

Pediatric vs. adult living donor kidney transplantation: A comparative analysis from a high-volume tertiary center

Jasmine Sethi (IN)

Bio Abstract

P1.045

Surgical outcomes of paediatric renal transplant- 5 year experience from a tertiary care hospital

Jaymeen Makwana (IN)

Bio Abstract

P1.046

Fully HLA matched kidney transplants in children: a 30-year case series in New South Wales

Josiah Shanks (AU)

Bio Abstract

P1.047

Childhood cancer following kidney transplantation: a 25-year experience

Julia Donald (AU)

Bio Abstract

P1.048

Cryptogenic organising pneumonia in a paediatric kidney transplant recipient

Julia Donald (AU)

Bio Abstract

P1.049

Belatacept use in paediatric renal transplant patients in an Australian tertiary paediatric centre

Christopher Alexander (AU)

Bio Abstract

P1.050

Catch up growth in children following renal transplantation: Observations from an emerging pediatric renal transplant center in south Asia

Deepthi R V (IN)

Bio Abstract

P1.051

Pediatric Kidney Transplant: A multi-center Study from Pakistan

Saeed Akhter (PK)

Bio Abstract

P1.052

Long-term growth velocity, nutritional rehabilitation, and graft function in paediatric kidney transplant recipients: a single-centre follow-up study at Cho Ray Hospital, Vietnam

Hien Nguyen (VN)

Bio Abstract

P1.053

Patient and caregiver perspectives on mental health in children with chronic kidney disease: A systematic review of qualitative studies

Luca Torrisi (AU)

Bio Abstract

P1.055

Evolution of nocturnal blood pressure after paediatric kidney transplantation

Kriscara Singh (AU)

Bio Abstract

P1.056

Multiorgan Transplantation in a Single Paediatric Hospital in Australia  

Mahnoor Bakhtiar (AU)

Bio Abstract

P1.057

Determinants of Graft Loss in Pediatric Deceased Donor Kidney Transplantation: The Limited Role of Donor Size Under Size-Matched Allocation

Qiang Zhang (CN)

Bio Abstract

P1.058

Assessing cardiovascular risk in paediatric kidney transplant recipients

Sarah Marokakis (AU)

Bio Abstract

P1.059

Barriers and facilitators to school attendance and sport participation in children with a kidney transplant

Siah Kim (AU)

Bio Abstract

P1.060

Distinct immunosuppressive and inflammatory profiles in early- and late-onset post-transplant lymphoproliferative disorder after pediatric liver transplantation

Figen Ozcay (TR)

Bio Abstract

P1.062

Management strategy for portal vein complications after living donor liver transplantation in children

Muthukumarassamy Rajakannu (IN)

Bio Abstract

P1.063

Transition to Adult Services After Paediatric Liver Transplantation: Long-Term Clinical and Psychosocial Outcomes

Fadak Mohammadi (AU)

Bio Abstract

P1.064

Transition care for adolescent and young adult transplant recipients in Australia and New Zealand: A multicentre survey

Miranda Paraskeva (AU)

Bio Abstract

P1.065

Analysis of Insurance-Related Concerns in Solid Organ Transplantation: A Comparison of Adult and Pediatric Patient Perspectives from Online Health Communities

Rohan Thomas (US)

Bio Abstract

P1.066

Pediatric Organ Transplantation in China

Björn Nashan (CN)

Bio Abstract

P1.067

The need for a specific paediatric protocol for organ and tissue donation

MJ Siebelink (NL)

Bio Abstract

P1.068

Survey of ISODP 2025 attendees on family support in pediatric organ donation after brain death

Natsuko Ishii (JP)

Bio Abstract

Presentations

P1.070

High Burden of Urinary Tract Infection After Kidney Transplantation in Bali, Indonesia: Gram-Negative Predominance and the Potential Role of Prolonged Catheterization

Gede Wira Mahadita (ID)

Bio Abstract

P1.071

Antiviral Management Patterns and Long-term Outcomes in HBsAg-Positive Kidney Transplant Recipients: A Retrospective Cohort Study

Rong Bao (CN)

Bio Abstract

P1.072

A novel way to increase the deceased donor pool by utilizing organs from hbv and hcv positive viremic donors- experience from a tertiary centre in India

Anu Ramesh (IN)

Bio Abstract

P1.073

Donor derived transmission in kidney transplant recipients in the setting of positive donor blood and urine cultures

Helen Tang (AU)

Bio Abstract

P1.076

Bloodstream Infections Among Solid Organ Deceased Donors

Sara Dionne (US)

Bio Abstract

P1.077

Primary cutaneous cryptococcosis in a renal transplant recipient : A case-report

Arsh Desai (IN)

Bio Abstract

P1.078

Beyond the graft: severe cutaneous cryptococcus in a kidney transplant recipient

Catherine Jolghazi (AU)

Bio Abstract

P1.079

Post transplant parvovirus infection: Strategic management of a double edged sword

Belmin B J Winston Gysley (IN)

Bio Abstract

P1.080

Evolution of Cytomegalovirus Management Strategies in Kidney Transplantation: A Single-Center Experience Over 15 Years

Cheng-Hsu Chen (TW)

Bio Abstract

P1.081

Healthcare Resource Utilization Burden associated with Leukopenia or Neutropenia after Kidney Transplantation

Fernanda Ortiz (FI)

Bio Abstract

P1.082

The rare entity of cytomegalovirus cholecystitis: A case report

Harsha Suresh (AU)

Bio Abstract

P1.083

Disseminated adenovirus and rejection in a kidney transplant recipient: Walking the fine line between infection and rejection

Hilary Hiscock (AU)

Bio Abstract

P1.084

Eliminating transmission of HTLV-1 in cadaveric organ transplantation: Our experience in Japan, one of the endemic regions in the world

Juntaro Ashikari (JP)

Bio Abstract

P1.085

Incidence of BK virus in HIV-positive kidney transplant recipients: Case Series from South Africa

Laurie Bertels (ZA)

Bio Abstract

P1.088

Direct clinical comparison of three commercial BK polyomavirus DNA assays in plasma specimens: Alinity m BKV, cobas BKV, and panther fusion BKV

Megan Gooey (AU)

Bio Abstract

P1.089

Long term evaluation of CMV-specific immunity in late kidney transplant recipients with and without CMV disease

Michelle Yong (AU)

Bio Abstract

P1.090

Maribavir efficacy and safety by baseline neutropenia status in solid organ transplant recipients with refractory cytomegalovirus: post hoc analysis of phase 2 and 3 trials

Nassim Kamar (FR)

Bio Abstract

P1.091

Passenger lymphocyte syndrome in hepatitis c exposed donor organs: Case insights

Raena Kaur (AU)

Bio Abstract

P1.092

Clinical outcome with low dose CMV prophylaxis in Indian kidney transplant recipients

Ramanand Sivaprasad (IN)

Bio Abstract

P1.093

Clinicopathological spectrum of polyoma virus nephropathy in renal allografts: A 15 year single centre experience

Ridam Shrinesh Agrawal (IN)

Bio Abstract

P1.094

Pritelivir for treatment of resistant/refractory HSV in stem cell transplant patients: Real-world experience from a single centre tertiary hospital

Sadaf Ahmer (AU)

Bio Abstract

P1.095

Chronic persistent norovirus infection in renal transplant recipient and combination therapy with nitazoxanide and enteral immunoglobulin

Sadaf Ahmer (AU)

Bio Abstract

P1.096

CMV immune monitoring with quantiFERON-CMV during rejection Therapy in kidney transplant recipients: A prospective study

Adem Safak (TR)

Bio Abstract

P1.097

Cytomegalovirus and antiviral related outcomes in kidney transplant recipients over a 24-month period from an Australian transplanting centre.

Sharon Ho (AU)

Bio Abstract

P1.098

Comparison of herpes zoster incidence between live-attenuated and recombinant zoster vaccines in kidney transplant recipients

Taehyun Ban (KR)

Bio Abstract

P1.100

Multicenter evaluation of Alinity m BKV assay in plasma and urine: comparison with laboratory-developed tests across three centers

Yan Chin Tai (SG)

Bio Abstract

P1.101

Clinical performance of the alinity m EBV whole blood assay in a transplant monitoring setting

Yan Chin Tai (SG)

Bio Abstract

P1.102

Current status of CMV infection following kidney transplantation in Japan

Yuki Nakagawa (JP)

Bio Abstract

P1.103

Vaccine coverage in paediatric renal transplant recipients

Joanna Nathan (AU)

Bio Abstract

P1.104

Extended letermovir prophylaxis for cytomegalovirus in intermediate-risk (R+) kidney transplant recipients: A pilot real-world cohort study

Junji Uchida (JP)

Bio Abstract

P1.105

Screening for rare infections prior to solid organ transplantation

Usha Manickavasagar (AU)

Bio Abstract

P1.106

The hidden culprit: MRI and biopsy unmasking late-onset cerebral toxoplasmosis post kidney transplant

Khoi Lai (GB)

Bio Abstract

P1.107

Pandemic‑Ready Infectious Disease Testing of Donor Blood to Inform Transplantation Decision‑Making

Calister Umeh (AU)

Bio Abstract

P1.108

Disseminated Mycobacterium Tuberculosis (MTB) and Parvovirus in a Kidney Transplant Recipient. A Case Report.

Devamalar Simatherai (MY)

Bio Abstract

P1.109

Informing a national infection prevention and surveillance program for transplant recipients dash analysis of the PROSPER study

Priya Garg (AU)

Bio Abstract

P1.110

Single-centre retrospective review of infectious complications in kidney transplant recipients with antibody-medicated rejection treated with Daratumumab – Beware the troll

Wei Jian James Kang (SG)

Bio Abstract

Presentations

P1.115

Investigating the role of heparanase in organ allograft rejection and treatment

Katherine Baines (AU)

Bio Abstract

P1.116

Gene expression signatures that characterise BK polyomavirus associated nephropathy in kidney transplant recipients

Katherine Baines (AU)

Bio Abstract

P1.117

JAK inhibition in a kidney transplant recipient with primary myelofibrosis

Laura Bywater (AU)

Bio Abstract

P1.119

Donor-derived cell-free DNA as a noninvasive biomarker for detection of allograft rejection in indian kidney transplant recipients

Anurag Gupta (IN)

Bio Abstract

P1.120

Biomarkers in Donation After Circulatory Death Heart Transplantation: Troponin-I, Lactate and TNF-a do not predict severe Primary Graft Dysfunction

Campbell MacLean (AU)

Bio Abstract

P1.121

Fingernail Creatinine as a Novel Biomarker for Estimating Duration of Azotemia and Monitoring Renal Function in CKD and Post-Transplant Patients

Charan Bale (IN)

Bio Abstract

P1.122

A biopsy-correlated pilot study of donor-derived cell-free DNA as a biomarker for detection of kidney allograft rejection

Dinesh Khullar (IN)

Bio Abstract

P1.124

Implementation of dd-cfDNA testing for heart transplant surveillance in Australia demonstrates high analytical concordance

Felicity Lee (AU)

Bio Abstract

P1.125

Establishment of Patient-Derived heterogeneous organoid models for hepatobiliary cancer and identification of biomarkers

Ji Hoon Jeong (KR)

Bio Abstract

P1.126

Dehydroepiandrosterone sulfate as a primary biomarker of bllostatic load in kidney transplant recipients

Maria Eugenia Garay (AR)

Bio Abstract

P1.127

Bridging Immune Detection and Clinical Decision-Making in Liver Transplantation: A Structured Interpretive Framework for Biomarker Integration

Rajdeep Das (US)

Bio Abstract

P1.128

Torque-Teno virus as potential biomarker in kidney transplant patients

Ruben Omar Schiavelli (AR)

Bio Abstract

P1.129

Donor-derived cell-free DNA as a noninvasive biomarker for diagnosis and monitoring of acute rejection after liver transplantation

Shaojun Ye (CN)

Bio Abstract

P1.130

Identifying TPIAT Candidates: WGS analysis of novel pathogenic variants in hereditary pancreatitis

Denghao Wu (AU)

Bio Abstract

P1.131

Spatial analysis of the cellular landscape and fibrotic signalling in hereditary pancreatitis

James Zuiani (AU)

Bio Abstract

P1.132

Low concentrations of saracatinib promote definitive endoderm differentiation through inhibition of FAK-YAP signaling axis

Xiaoming Ding (CN)

Bio Abstract

P1.134

GMFB drives mitochondrial dysfunction and promotes mash progression via inhibition of mitophagy

Yuan Ding (CN)

Bio Abstract

P1.136

Neuromodulation via alpha7 nicotinic acetylcholine receptor signaling restrains alloimmunity and prolongs transplant survival

Stefan Tullius (US)

Bio Abstract

P1.137

Short-course anti-CD154 induction followed by tacrolimus maintenance sustains pig-to-cynomolgus kidney xenograft function

Sun Ae Hwang (KR)

Bio Abstract

P1.138

Mycophenolic acid suppresses human monocyte-macrophage cytotoxicity against swine endothelial cells through guanosine depletion

Yusuke Yanagino (JP)

Bio Abstract

P1.139

Investigation of the effect of donor-specific antibody presence on NKG2D expression on natural killer cell surface

Bilkay Basturk (TR)

Bio Abstract

P1.140

Targeting NOX2 to mitigate cardiac allograft rejection: The inhibitor GSK2795039 attenuates macrophage activation by suppressing oxidative stress in mice

Difei Ren (CN)

Bio Abstract

P1.141

The safety and efficacy of regulatory T cell therapy in kidney transplant recipients: A systematic review

Emilie Wu (AU)

Bio Abstract

P1.142

Activation of antigen specific CD4+CD25+Foxp3+T regulatory cells that mediate antigen specific regulation from non-antigen specific Treg

Nirupama Verma (AU)

Bio Abstract

P1.143

Changes in Treg subpopulations and cytokine receptor expression in human CD4+CD25+CD127lo Treg upon activation with alloantigen and rIL-2

Ranje Al-Atiyah (AU)

Bio Abstract

P1.144

ALC guided precision ATLG induction dosing strategy: a tool in optimising outcomes in Kidney Transplant recipients

Akash Gupta (IN)

Bio Abstract

P1.145

Immune monitoring and prediction of allograft injury using biomarkers in kidney transplant recipients with malignancy receiving immune checkpoint inhibitors.

Itunu Owoyemi (US)

Bio Abstract

P1.146

Everolimus-Based De Novo Immunosuppression with Low-dose Tacrolimus in High-risk Third cadaver Kidney Retransplantation: A case report

Kshitija Gadekar (IN)

Bio Abstract

P1.147

Assessment of Tacrolimus pharmacokinetics based on CYP3A5 genotypes and weight-based initial dosage in kidney transplant recipients- A single center study

Ravi Eslavath (IN)

Bio Abstract

P1.149

Oestrogen-associated downregulation of acid sensing ion channel (ASIC) 1a expression leads to reduced recovery of rat hearts following prolonged cold storage

Sanjay Dutta (AU)

Bio Abstract

P1.150

T Cell Responsiveness and Procalcitonin in Kidney Transplant Recipients

Alain Assounga (ZA)

Bio Abstract

P1.151

Eculizumab Monotherapy as First-Line Treatment for Early-Onset De Novo Thrombotic Microangiopathy Following ABO-Incompatible Kidney Transplantation: A Case Series

Yu Cui (CN)

Bio Abstract

P1.152

Once-monthly long-acting injectable tacrolimus with high bioavailability and low fluctuation: A potential strategy to imporve transplant outcomes

Heejun Shin (KR)

Bio Abstract

P1.153

Functional characterisation of the novel R636H RBM20 mutation and development of a targeted adenine base editing strategy

Jennifer Rigterink (AU)

Bio Abstract

P1.155

ATLG induction at lower dose in kidney transplant-effective and cheaper

Pavan Kumar Navva (IN)

Bio Abstract

P1.156

Engineering human regulatory T cells with a modular adaptor for programmable antigen targeting

Quan Yao Ho (SG)

Bio Abstract

P1.157

Fibroblast-Driven IL-6/IL-17 Amplifier Loop in Chronic Antibody-Mediated Rejection: A Therapeutic Target in Kidney Transplantation

Narayan Prasad (IN)

Bio Abstract

P1.158

Comparison of Protocol and Indication Biopsies and Their Association with Donor-Specific Antibodies and Treatment Outcomes in Renal Transplant Recipients

Narayan Prasad (IN)

Bio Abstract

P1.159

Single-cell profiling of CD8+ T cell dysfunction after allogeneic stem cell transplantation

Katie Lineburg (AU)

Bio Abstract

P1.160

Puerarin targets MIC19 to suppress mitochondrial metabolism of tumor-infiltrating Tregs and enhance anti-tumor immunity

Yu Li (CN)

Bio Abstract

P1.161

Suppression of activated circulating follicular helper T cells correlates with improved graft function after kidney transplantation

Yusuke Tomita (JP)

Bio Abstract

P1.162

Peripheral T cell transcriptomic profile is altered in non-human primate kidney transplant recipients treated with ECDI-fixed donor B cell infusions

Matthew Tunbridge (AU)

Bio Abstract

P1.163

Significance of treatment applying fetal-mother immune tolerance in transplantation

Shin Do Suh (KR)

Bio Abstract

P1.164

First successful liver and kidney transplant with use of low-cost hybrid abdominal normothermic regional perfusion for DCD in India

Avnish Seth (IN)

Bio Abstract

P1.165

🎗Chronic active antibody mediated rejection treatment with IL-17Ai plus IL-6i in kidney transplant

Lucino Bahena Carrera (MX)

Bio Abstract

P1.166

Donor-derived cell-free DNA among the kidney transplant recipient allograft biopsies at University Malaya Medical Centre and their 1-year graft outcomes.

Maisarah Jalalonmuhali (MY)

Bio Abstract

P1.167

Regulatory B-1 Cell Subsets Modulate Indirect Alloimmune Responses via IL-10–Dependent Mechanisms

Yuka Tanaka (JP)

Bio Abstract

P1.168

Correlation between Human Leukocyte Antigen (HLA) Eplet Mismatch and Denovo Donor Specific Antibodies (dnDSA) development in Paediatric Kidney Transplant Recipients (KTR): A retrospective cohort from a single Indian Centre

Kinnari Vala (IN)

Bio Abstract

P1.169

Dynamic biomarkers for adverse graft outcomes prediction in kidney transplantation recipients with BK Polyomavirus associated nephropathy

Maggie Kam Man Ma (HK)

Bio Abstract

P1.170

Role of miRNA as a potential biomarker for diagnosing post transplant kidney graft rejection

Sai Praneeth Reddy Perugu (IN)

Bio Abstract

P1.171

Diminished TCF-1 expression following hematopoietic stem cell transplantation impairs T cell responses to vaccination

Cheng Sheng Chai (AU)

Bio Abstract

P1.172

The leukocyte landscape across mouse strains and tissues

Ella Trolio (AU)

Bio Abstract

P1.173

Development of 3D Cell pool models from Isolated Primary Liver cells microencapsulated through bioprinting

Estephan Arredondo (ES)

Bio Abstract

P1.174

Human NK Cell Activation by Porcine cells Compared to Allogeneic Human Cells

Eunjee Oh (KR)

Bio Abstract

P1.175

10-year cohort of donor-transmitted cancer in organ donation and transplantation in Germany from 2016-2025

Ana Paula Barreiros (DE)

Bio Abstract

P1.177

Histological evaluation of cryopreserved venous allografts used for liver transplantation and hepato-biliary-pancreatic surgery: Tissue chimerism, with the presence of viable donor cells and recipient-derived cells

Yusuke Seki (JP)

Bio Abstract

P1.178

Novel RORγ inverse agonists: Dual-action therapy for promoting graft tolerance while inhibiting tumor growth

Jean Tchervenkov (CA)

Bio Abstract

Presentations

P1.180

Extending the viability of ex-vivo body tissues

Bhavika Mahajan (AU)

Bio Abstract

P1.182

Cold comfort: Viability testing in Australasia’s first hypothermic machine perfusion programme for liver transplantation

Jacques Eastment (AU)

Bio Abstract

P1.184

Establishing Liver and Kidney Machine Perfusion Platforms for Translational Research in Paediatric Organ Transplantation

Zahra Lotfibakalani (AU)

Bio Abstract

P1.185

Does size matter? Perfusion characteristics and outcomes for large livers undergoing normothermic machine perfusion - A retrospective review

Damon Li (AU)

Bio Abstract

P1.186

Portal venous oxygen delivery during normothermic machine perfusion and its association with post-transplant acute kidney injury

Danielle La Vigne (US)

Bio Abstract

P1.187

136 hours of Long Term Normothermic Machine Perfusion of Human Kidneys

Hayden Ly (AU)

Bio Abstract

P1.189

Normothermic machine perfusion enables high-risk donation after circulatory death liver transplantation without compromising biliary outcomes

Robert Torode (AU)

Bio Abstract

P1.190

Static cold ischemic time prior to normothermic machine perfusion: a clinnical investigation of perfusate lactate and liver enzymes.

Shaheed Merani (US)

Bio Abstract

P1.191

Decoding immune landscape and intracellular crosstalk in the steatotic livers during normothermic machine perfusion

Zhixin Liang (CN)

Bio Abstract

P1.192

Objective Viability Classification of Porcine Hearts During Normothermic Ex Vivo Perfusion Using a Multimodal Convergence Score

Syed Raza (US)

Bio Abstract

P1.193

Pretransplant Assessment of Donor Kidney Perfusion Using Transit-Time Flow Measurement (Medistim): A Prospective Pilot Study

Igor Miloserdov (RU)

Bio Abstract

Presentations

P1.195

Combined liver pancreas transplant for cystic fibrosis dash 10yr experience of a single center

Isabela Gusson Galdino dos Santos (AU)

Bio Abstract

P1.196

Establishing research priorities in solid organ transplantation: a systematic review

Javier Recabarren Silva (AU)

Bio Abstract

P1.197

Prelisting Mortality in Massive Polycystic Liver–Kidney Disease: An Allocation Gap

Maggie Kam Man Ma (HK)

Bio Abstract

P1.198

Organ Allocation Challenges After Stem Cell Transplantation: Lessons from Three Deceased Donor Cases

Purvesh Patel (AU)

Bio Abstract

Presentations

P3.500

Incidence, management and clinical Outcomes of perigraft fluid collection (PGFC) among kidney transplant recipients in a tertiary government hospital: A six-year retrospective review

Esviel Payte (PH)

Bio Abstract

P3.501

Plasma and urine donor-derived cell-free DNA for the detection of kidney allograft injury

Bin Shen (CN)

Bio Abstract

P3.502

Clinical features and risk factors of new-onset urinary calculi after kidney transplantation: a propensity score-matched study

Xiaoming Zhang (CN)

Bio Abstract

P3.503

Clinical analysis of liver transplantation in patients with severe liver disease

Jinzhen Cai (CN)

Bio Abstract

P3.504

Protective value of ischemia-free liver transplantation on long-term major adverse cardiovascular events after transplantation

Meng Qingze (CN)

Bio Abstract

P3.505

Streamlining donation & transplant country-wide with comprehensive and secure digital platforms

Aditi Srinivasan (US)

Bio Abstract

P3.506

Launching potential donor referral interface across Canadian province

Christian Rivas (US)

Bio Abstract

P3.507

OrganMatch – Australia’s digital backbone for organ donation and transplantation

Narelle Watson (AU)

Bio Abstract

P3.508

Dermatological Findings, Infectious Comorbidities, and Quality of Life in Patients Under Evaluation for Solid Organ Transplantation: Opportunities for Digital Health Integration in a Resource-Limited Setting

Shambhu Joshi (NP)

Bio Abstract

P3.510

Bridging the prediction gap: Machine learning–based risk stratification of 3-year kidney graft survival using the indonesian national transplant registry

Hendra Perkasa (ID)

Bio Abstract

P3.511

Developing a prediction model for the time from withdrawal of cardiorespiratory support to death in controlled donation after circulatory determination of death donors

Ryan Gately (AU)

Bio Abstract

P3.512

Predicting First Year Kidney Graft Loss from First-Month Clinical Information: A Prognostic Prediction Model using Random Survival Forest for Competing Risks

Sergio Salcedo Herrera (CO)

Bio Abstract

P3.513

Impact of AI in Kidney Transplantation: organ matching, allocation, delayed graft function, rejection, and immunosuppression

D. Olga McDaniel (US)

Bio Abstract

P3.515

🎗Advancing prognostic models for competing risks in renal transplant outcomes: A comparative study of statistical and machine learning approaches

Getahun Mulugeta Awoke (ET)

Bio Abstract

P3.516

Developing clinical prognostic models to predict graft survival after renal transplantation: Comparison of statistical and machine learning models

Getahun Mulugeta Awoke (ET)

Bio Abstract

P3.518

Real-world analysis of organ transplantation-specific agent based on large language model in post-transplant self-management during off-hours: A mixed-methods study

Shaojun Ye (CN)

Bio Abstract

P3.519

Designing compassion-informed AI decision-support pathways to enhance resilience among organ donation coordinator nurses

Vanessa Silva e Silva (CA)

Bio Abstract

P3.520

AI-enabled comprehensive management for liver transplant patients

Weiqing Luo (CN)

Bio Abstract

P3.521

Impact of the COVID-19 pandemic on trends in causes of mortality in the Asian transplantation registry ASTREG H

Astreg Astreg (KR)

Bio Abstract

P3.522

Evaluation of trends of live renal transplantation in India over the last decade – A retrospective cohort study of nationwide survey database

Vasanthi Ramesh (IN)

Bio Abstract

P3.523

Evaluation of trends of pediatric renal transplantation over the last decade – A retrospective cohort study of nationwide survey database

Vasanthi Ramesh (IN)

Bio Abstract

P3.524

Forbes Top Hospitals 2026 star ratings do not reflect SRTR 1-year graft survival in adult liver, kidney and heart transplant centers

Gavin McAfee (US)

Bio Abstract

P3.525

Demographics and outcomes of indigenous Australian, Māori, and Pasifika renal transplant recipients: A 10-year retrospective cohort study from a tertiary health service in Victoria, Australia

James Crispin (AU)

Bio Abstract

P3.526

Decision support tool to simulate waiting time for an individual patient under the new Australian kidney allocation system

James Hedley (AU)

Bio Abstract

P3.527

Healthcare Resource Utilization and Cost Concentration Across the Treatment Journey in Transplant Recipients with PTLD: A U.S Claims Analysis

Jenny Bui (AU)

Bio Abstract

P3.528

Projected Kidney Failure Burden and Treatment Gap in South Africa’s Public Sector

Kathryn Manning (ZA)

Bio Abstract

P3.529

Transplantation improves patient survival in a PD-first programme in South Africa

Kathryn Manning (ZA)

Bio Abstract

P3.530

Implementation of the critical pathway for deceased organ donation in the United Arab Emirates: national outcomes 2023–2025

Maria Gomez (AE)

Bio Abstract

P3.531

Prevalence and associated etiologies of chronic kidney disease: A registry-based descriptive study

Mark Lenon Tulisana (PH)

Bio Abstract

P3.532

Attenuation of the Association Between Immunologic Risk and Graft Failure Across Kidney Transplantation Across Eras: A Single-Center Experience of 4,024 Cases

Seunghyeon Kim (KR)

Bio Abstract

P3.534

Computed Tomography Angiography as a practical ancillary Test for Brain Death Certification in India

Vishal Garg (IN)

Bio Abstract

P3.535

Renal auto-transplantation in children: A systematic review and meta-analysis on indications, techniques and outcomes

Adrian Chi-Heng Fung (HK)

Bio Abstract

P3.537

Successful multiorgan utilization after fatal fat embolism syndrome in a deceased donor

Johan Nordström (SE)

Bio Abstract

P3.538

Peri-operative Practices in kidney transplantation: a survey of transplanting units in Australia and New Zealand

Karthik Venkataraman (AU)

Bio Abstract

P3.539

National analysis of deceased organ donation and transplantation activity in Saudi Arabia, 2025

Lina Aldakhil (SA)

Bio Abstract

P3.540

Perioperative plasma GLP-1 dynamics in liver transplantation: Association with T cell-mediated rejection and disease severity

Masaaki Ito (JP)

Bio Abstract

P3.541

Infectious complications and outcomes following sequential solid organ transplantation and hematopoietic stem cell transplantation

Michelle Gonzalez Ramos (PR)

Bio Abstract

P3.542

Dialysis initiation patterns after kidney allograft failure: A single-centre study

Monika Ashwin (US)

Bio Abstract

P3.543

Evaluation of donor hepatic steatosis as a predictor of post-transplant mortality: A retrospective study

Parisa Keshani (IR)

Bio Abstract

P3.544

Hepatocellular Carcinoma with Pulmonary Metastasis Two Years After Liver Transplantation: A Case Report and Multidisciplinary Management

Qiang Fu (CN)

Bio Abstract

P3.548

Impact of everolimus combination therapy on CNI nephropathy and rejection after kidney transplantation: Evaluation using Klotho immunohistochemistry

Shunta Hori (JP)

Bio Abstract

P3.549

ABO incompatibility and liver allograft T cell mediated rejection in infants

Suzan Warner (AU)

Bio Abstract

P3.550

Deceased Donor Organ Donation at Cho Ray Hospital, Vietnam: A 17-Year Analysis of Consent Rates, Barriers, and Donor Characteristics (2008–2025)

Thu Du (VN)

Bio Abstract

P3.551

🎗Risk factors analysis of post-transplant thrombotic microangiopathy

Yang Li (CN)

Bio Abstract

Presentations

P3.554

Immune invisible kidney allografts: eliminating MHC II expression with cytosine base editing to prevent antibody-mediated kidney transplant rejection

Ailish Barry (AU)

Bio Abstract

P3.555

Selective preservation of accessory and polar renal arteries in kidney transplantation with complex vascular anatomy: A single-surgeon experience

Carlos Lobos (CL)

Bio Abstract

P3.556

Negative pressure wound therapy for delayed abdominal closure in small pediatric kidney transplant recipients: A single-center case series

Patimat Gadzhieva (RU)

Bio Abstract

P3.557

Cocaine kidneys: Early kidney allograft failures suggesting occult donor-derived renal microvascular injury

Karunya Venkada Subramaniyan (AU)

Bio Abstract

P3.558

Temporal trends and determinants of graft survival and slow graft function in deceased donor kidney transplantation: Influence of donor, recipient, and perioperative factors across eras: Single Centre 20 years experience from India

Sourya Mohakuda (IN)

Bio Abstract

P3.559

Deceased donor kidney transplant: Standard criteria versus expanded criteria donors - 1 year single centre experience

VISHAL PARMAR (IN)

Bio Abstract

P3.560

A Prospective Comparative Study Of Three Different Induction Agents In ABO Incompatible Renal Transplantation From a Tertiary Care Centre In India

Pratik Das (IN)

Bio Abstract

P3.561

Long-term outcomes of ABO incompatible transplants in a tertiary care centre

Shyam Bihari Bansal (IN)

Bio Abstract

P3.563

Successful Renal Transplantation in a Patient With Methylmalonic Acidemia and ESRD: A Case Report

Sonal Dalal (IN)

Bio Abstract

P3.564

A case of refractory antibody-mediated rejection post kidney transplantation treated with daratumumab

Robert Ellis (AU)

Bio Abstract

P3.565

Surgical outcomes in elderly kidney transplantation recipients

Ela Curic (AU)

Bio Abstract

P3.567

From fluid to fat: Bioimpedance mapping in kidney transplant recipients

Charan Bale (IN)

Bio Abstract

P3.568

Intra-operative and early post-operative cortical resistive Indices in renal transplantation: Representative values according to graft function and time of scan

Charles Fisher (AU)

Bio Abstract

P3.569

🎗Validation of a novel non-invasive method based on evaluating urinary exfoliated proximal tubule kidney cell multispectral autofluorescence to differentiate between causes of kidney transplant complications

Henry H L Wu (AU)

Bio Abstract

P3.570

Understanding HLA-DQ antibody epitope patterns in south indian transplant recipients: A single-centre eplet-based study

Krishnakumar VR (IN)

Bio Abstract

P3.571

The distribution and pairing patterns of HLA-DQA1 and HLA-DQB1 alleles in a South Indian population offer insights into current understanding of HLA-DQ biology

Krishnakumar VR (IN)

Bio Abstract

P3.572

Changing Spectrum and Determinants of Renal Allograft Dysfunction and outcome: A Fifteen year Clinicopathological Analysis from a resource limited tertiary care centre in central India

Kshitija Gadekar (IN)

Bio Abstract

P3.573

Complement binding Donor specific HLA antibodies can be used to immunestartify and facilitate transplant in broadly sensitized recipients

Shruti Tapiawala (IN)

Bio Abstract

P3.574

Laparoscopic assisted right donor nephrectomy- Experience from tertiary care transplant unit

Akshay Ghumare (IN)

Bio Abstract

P3.575

An unsual case of late onset mycophenolate mofetil induced pancytopenia with sterile oral ulcers in a kidney transplant recipient: A case report

Amresh Krishna (IN)

Bio Abstract

P3.576

Quantifying the Need for Donor Pool Expansion in Sensitized Kidney Transplant Candidates: A Group-Based Probabilistic Model from Malabar Region, Kerala State India

Feroz Aziz (IN)

Bio Abstract

P3.578

Laparoscopic vs robotic donor nephrectomy in living donor transplant- Experience from a tertiary care referral centre in India

Krishna Asuri (IN)

Bio Abstract

P3.579

Unexplained weight loss In renal transplantation.

Pinaki Mukhopadhyay (IN)

Bio Abstract

P3.580

Post renal transplant myeloma--An experience from tertiary care hospital.

Pinaki Mukhopadhyay (IN)

Bio Abstract

P3.581

Monitoring long-term renal health: A recovery trajectory study of living kidney donors in India

Ruchir Dave (IN)

Bio Abstract

P3.582

Successful Kidney Transplantation in a High-Risk Diabetic Recipient with Early Multi-System Complications: A Case Report

Shalini Sinha (IN)

Bio Abstract

P3.584

Long-Term Renal Function and Survival After Living Kidney Donation: A Cohort Study of 2,085 Indian Kidney Donors

Sheenam Dhiman (IN)

Bio Abstract

P3.585

Assessment of Carotid Intima-Media Thickness in Post Renal Transplant Patients and Its Association with Cardiovascular Risk Factors

Vaanmathi Azhagar Nambi Santhi (IN)

Bio Abstract

P3.587

Predictors of adherence to skin cancer screening guidelines among renal transplant recipients

Will Swansson (AU)

Bio Abstract

P3.588

Prediabetes and diabetes are prevalent in adults with kidney failure on the kidney transplant waiting list and increases following transplantation

Karen Dwyer (AU)

Bio Abstract

P3.589

Dietary modification supported by Mobile App use improves post-transplant dysglycemia

Karen Dwyer (AU)

Bio Abstract

P3.590

Challenging case of surgically refractory uraemic leontiasis ossea improving post kidney transplant

Liam Qi (AU)

Bio Abstract

P3.591

Incidence and predictors of post-transplant diabetes mellitus in renal transplant recipients: A single-centre retrospective study.

Meet Thakkar (IN)

Bio Abstract

P3.592

Brown Tumor Mimicking Metastatic Bone Disease in a Post–Renal Transplant Patient with CKD-MBD: A Diagnostic Challenge

Ravi Eslavath (IN)

Bio Abstract

P3.593

Peri-operative parameters associated with delayed graft function in kidney transplant patients

Yin Shuo Yang (TW)

Bio Abstract

P3.594

Integrating CT Calcification and Doppler PI for Enhanced Prediction of Renal Graft Recovery after Kidney Transplantation

Yin Shuo Yang (TW)

Bio Abstract

P3.595

Quality of Life Among Long-Term Living Kidney Donors: Assessment Using the SF-36 questionnaire

Alejandro Nino Murcia (CO)

Bio Abstract

P3.596

Clinical Factors Associated with Delayed Graft Function in Kidney Transplantation: Evidence from a Colombian Cohort

Alejandro Nino Murcia (CO)

Bio Abstract

P3.597

🎗Successful living-donor kidney transplantation in a homozygous hemoglobin C recipient from a heterozygous donor

Amos Gonzalez Compres (DO)

Bio Abstract

P3.598

Identifying cardiovascular outcomes of importance in kidney transplant clinical trials: An international survey

Andrea Matus (AU)

Bio Abstract

P3.599

Report of the SONG-Tx cardiovascular disease consensus workshops

Andrea Matus (AU)

Bio Abstract

P3.600

Extreme heat effects on kidney transplant recipient outcomes

Anna Nguyen (US)

Bio Abstract

P3.601

🎗Cardiac structural and functional recovery after renal transplantation: A prospective echocardiographic study of 250 patients from India

Bhavjot Singh (IN)

Bio Abstract

P3.602

From telomere disorder to successful renal transplantation: staged splenectomy as a bridge in a patient with TERT mutation and end-stage renal disease

Bhavjot Singh (IN)

Bio Abstract

P3.605

Experience of Clinical Surveillance of Brain Death for Transplant Purposes in Adult Patients at Hospital General San Juan de Dios, Guatemala

Cindy Ixpancoc (GT)

Bio Abstract

P3.606

Endovascular management of very early transplant renal artery stenosis

Fatih Boyvat (TR)

Bio Abstract

P3.607

Effect of closed-incision negative wound pressure therapy on wound healing after kidney transplantation

Frederik Deutch (DK)

Bio Abstract

P3.608

Obesity, weight loss and surgical wound complications following renal transplantation: A case series

Hamish McDonald (AU)

Bio Abstract

P3.609

Outcomes of Pediatric Kidney Transplantation in CAKUT vs Non-CAKUT Recipients

Haneen Yamin (AE)

Bio Abstract

P3.610

Growth and Nutritional Trajectories in Pediatric Kidney Transplant Recipients: A Longitudinal Analysis of BMI, Height Recovery, and Graft Function

Haneen Yamin (AE)

Bio Abstract

P3.611

Graft nephrectomy following kidney allograft failure: A single-centre descriptive cohort study

Henry Guo (AU)

Bio Abstract

P3.612

Association of donor aortic calcification with 1-year allograft function following living-donor kidney transplantation

Himawari Asanuma (JP)

Bio Abstract

P3.613

Development of a prediction model of kidney function for post-transplant prognostic assessment

Hirotake Kodama (JP)

Bio Abstract

P3.614

Aortic calcification trajectories and outcomes: Hemodialysis vs living-donor kidney transplantation

Hirotake Kodama (JP)

Bio Abstract

P3.615

Thirty-four years of kidney transplantation at Cho Ray hospital, Viet Nam

Hoang Chuan (VN)

Bio Abstract

P3.617

Limited association of intraoperative blood pressure with slow or delayed graft function despite favorable early renal recovery

Hyo Eun Ahn (KR)

Bio Abstract

P3.618

Impact of pre-transplant dialysis modality on post-transplant atrial fibrillation in kidney transplant recipients: a nationwide cohort study

Hyunjeong Cho (KR)

Bio Abstract

P3.619

Thrombotic Microangiopathy post Simultaneous Pancreas-Kidney (SPK) transplant: a challenging scenario

Isra Iftikhar (AU)

Bio Abstract

P3.620

Successful Sequential Renal Transplantation in Lung Transplant recipients.

Isra Iftikhar (AU)

Bio Abstract

P3.621

Clinical outcomes of deceased donor kidney transplantation in patients with cardiovascular disease

Ju Ik Moon (KR)

Bio Abstract

P3.622

Long-term outcomes and prognostic factors for patient and graft survival among kidney transplant recipients in the Philippines

Katherine Ruth Relato (PH)

Bio Abstract

P3.625

Who benefits from plasmapheresis, IVIG, and rituximab in AMR? Development of a clinical decision tree

Adem Safak (TR)

Bio Abstract

P3.626

Graft and recipient outcome of deceased donor kidney transplantation at national kidney and transplant institute from 2014 to 2023 (period of hypothermic perfusion). A 10-year retrospective study

Lauro Gabriel Noel (PH)

Bio Abstract

P3.627

Outcomes of pre-emptive kidney transplantation from living donors: a single center experience at Cho Ray Hospital

Huu Thuan Le (VN)

Bio Abstract

P3.629

Structural pattern of kidney allograft dysfunction in the late period after COVID 19 infection

Ludmila Artyukhina (RU)

Bio Abstract

P3.630

Impact of Tacrolimus Exposure on Graft and Patient Outcomes in Kidney Transplant Recipients: A Retrospective Cohort Study

Maisarah Jalalonmuhali (MY)

Bio Abstract

P3.631

Multiplex PCR-based etiological profiling of diarrhea and its impact on graft dysfunction in renal transplant recipients

Manish Malik (IN)

Bio Abstract

P3.632

One-year graft and patient outcomes among obese kidney transplant recipients at National Kidney and Transplant Insitute

Marichel Coronel (PH)

Bio Abstract

P3.635

Kidney Transplantation in Patients with a Previous History of Femoral Lines: Surgical Challenges and Outcomes

Muhammad Izhar (PK)

Bio Abstract

P3.637

Surgical Implications of the Modified Parachute Anastomotic Technique: Doppler Ultrasound Alterations and their relationship to graft outcomes

Muhammad Izhar (PK)

Bio Abstract

P3.638

Profile of avascular necrosis cases among kidney transplant recipients on a low-dose steroid regimen. A retrospective study

Muhammad Tassaduq Khan (PK)

Bio Abstract

P3.640

Impact of pre-transplant donor-specific antibodies on patient and graft outcomes after kidney transplantation: A matched cohort study from a single-center in Vietnam

Nguyen Xuong Duong (VN)

Bio Abstract

P3.643

Kidney Transplantation from HBsAg-Positive and HBcAb-Positive Deceased Donors in Immunised Recipients: A Retrospective Cohort Study from Malaysia

Premila Peraba (MY)

Bio Abstract

P3.644

Long-term outcomes of kidney transplantation in Uzbekistan: A national cohort of 3,437 recipients reveals biphasic graft loss risk and real-world immunosuppression minimization

Pulat Sultanov (UZ)

Bio Abstract

P3.647

Roxadustat in CKD and transplant patients: A new era in anemia management

Rashid Hamid (PK)

Bio Abstract

P3.648

Early graft outcomes following fluid restrictions in postoperative care of kidney transplant

Santosh Nagaraju (US)

Bio Abstract

P3.649

Retrospective assessments on long-term outcomes of a quadruple CNI-sparing regimen with everolimus initiated 3-6 months after kidney transplantation

Satoshi Kitamura (JP)

Bio Abstract

P3.650

Association between vascular anastomosis time and risk of delayed graft function in deceased donor kidney transplantation

Sayeh Heidari Nejad (AU)

Bio Abstract

P3.651

Kidney transplantation outcome in Malaysia’s national public sector program: A decade’s analysis of 1113 transplants

Seow Yeing Yee (MY)

Bio Abstract

P3.652

Outcomes following transplantation in amyloidosis

Sumedh Jayanti (AU)

Bio Abstract

P3.653

Peri-operative cardiac index and vital signs as predictor of graft function, a artificial intelligence approach

Sy Yuan Chen (TW)

Bio Abstract

P3.654

The impact of perioperative graft flow and fluid transfusion on delayed graft function

Sy Yuan Chen (TW)

Bio Abstract

P3.655

Longitudinal native kidney involution after kidney transplantation in ADPKD and its limited association with graft function

Takayoshi Yokoyama (JP)

Bio Abstract

P3.656

Dialysis withdrawal after kidney allograft failure - temporal associations and risk factors

Tess Vermeulen (AU)

Bio Abstract

P3.657

Proteinuria In A Kidney Transplant Recipient: The Alloimmune Connection

Vamsee Chirumamilla (US)

Bio Abstract

P3.658

Impact of Obesity on Renal Transplant Outcomes: A Retrospective Cohort Study

Vidya Sagar Kallepalli (AU)

Bio Abstract

P3.659

The prognostic role and limitations of donor kidney remuzzi score in adult kidney transplant recipients

Xinchi Zhang (CN)

Bio Abstract

P3.660

Changes in Left Ventricular Geometry and Function After Kidney Transplantation

Yuki Tashiro (JP)

Bio Abstract

P3.661

RDW and inflammatory ratios differentially predict renal progression and mortality in non dialysis chronic kidney disease implications for pre transplant risk stratification

Yun-Kyeong Hwang (KR)

Bio Abstract

P3.662

Factors predicting access to pre-emptive or early kidney transplantation: An Australian national study

Alessandra Orsillo (AU)

Bio Abstract

P3.663

SPPB-defined frailty in kidney transplant candidates is driven by impairments in gait speed and chair stands and is strongly associated with diabetes

Amy Barnett (AU)

Bio Abstract

P3.664

Successful preemptive living-donor kidney transplantation in a young female with end-stage kidney disease from chronic glomerulonephritis complicated by secondary antiphospholipid antibody syndrome: a case report

Carlo Antonio Boado (PH)

Bio Abstract

P3.666

Desensitization-enabled kidney transplantation in hypersensitized recipients: A single-center experience with early outcomes

Ehtuish Ehtuish (LY)

Bio Abstract

P3.667

The utility of pre-transplant OGTT versus early post-transplant hyperglycaemia in predicting NODAT risk: A single centre study

Eliseus Feng (AU)

Bio Abstract

P3.668

Comprehensive malignancy profiling in kidney transplant candidates: A decadal single-center analysis

Eun Jung Shim (KR)

Bio Abstract

P3.669

Thirty Six Years of Kidney Allograft Survival Despite Multiple Post Transplant Complications

Fatima AlKindi (AE)

Bio Abstract

P3.672

Renal transplant in sensitized patients: SIUT experience

Khawar Abbas (PK)

Bio Abstract

P3.673

Impact of low-level pretransplant donor-specific antibodies detected by the Luminex platform on acute rejection and long-term graft survival

Khawar Abbas (PK)

Bio Abstract

P3.674

The role of pretransplant dialysis modality on early post-transplant period in patient after kidney transplantation

Vitalii Berdinskii (RU)

Bio Abstract

P3.675

Does frailty influence immediate kidney transplant selection? A comparison of the frailty index and fried frailty phenotype

Kaixin Li (AU)

Bio Abstract

P3.676

Outcomes of thigh loop arteriovenous graft and ipsilateral kidney transplantation: Case report and literature review

Stephanie Sum (AU)

Bio Abstract

P3.678

Retrospective outcome analysis of biopsy proven CA-TCMR in a tertiary care hospital in eastern India

Arpita Ray Chaudhury (IN)

Bio Abstract

P3.680

Prevalence and correlates of loneliness and social isolation in patients receiving kidney replacement including transplant recipients

Amanda Sluiter (AU)

Bio Abstract

P3.681

Post-Transplant Thrombotic Microangiopathy in Kidney Transplant Recipients: Clinical, Genetic, and Therapeutic Outcomes from a Single-Center Cohort

Amit Pasari (IN)

Bio Abstract

P3.682

Lymphangiography and Embolization for Post–Renal Transplant Lymphatic Complications: A Five-Case Series from Central India

Akshay Kriplani (IN)

Bio Abstract

P3.683

Refractory Psychosis After Kidney Transplantation Managed with Electroconvulsive Therapy: Sustained Psychiatric Recovery with Stable Graft Function

Amol Bhawane (IN)

Bio Abstract

P3.684

Successful renal transplant in a MYH9 gene related disorder with planned preoperative care

Amol Bhawane (IN)

Bio Abstract

P3.685

Impacts of research that are meaningful to people with chronic kidney disease, transplant recipients and their caregivers: a workshop report

Anastasia Hughes (AU)

Bio Abstract

P3.687

Costs in Contemporary Kidney Transplant Practice

Steve Chadban (AU)

Bio Abstract

P3.688

Predictors and treatment of moderate-to-severe hypophosphataemia following kidney transplantation

Catherine Mao (AU)

Bio Abstract

P3.689

PI3K-alpha activator increases renal cell size and reduces dendritic cell maturation: A potential strategy to improve donor kidney recovery

Darling Rojas-Canales (AU)

Bio Abstract

P3.690

Targeting premature ageing of the immune system in dialysis patients

Deborah Pratt (AU)

Bio Abstract

P3.691

Monitoring HLA antibodies after novel desensitisation treatments

Fiona Hudson (AU)

Bio Abstract

P3.692

"The triple threat: Managing concomitant bacterial, viral and fungal infections in a recent renal transplant recipient"

Gajera Jamanadas (IN)

Bio Abstract

P3.693

Community and patient attitudes and perspectives toward commercial kidney transplantation: A qualitative systematic analysis

Genevieve Mylne (AU)

Bio Abstract

P3.694

Spectrum of lower urinary tract symptoms after renal transplant and their management in a tertiary care centre

Kishani Shah (IN)

Bio Abstract

P3.696

Optimal timing for removal of indwelling urinary catheter after kidney transplantation: An integrative review

Ludmila Costa (BR)

Bio Abstract

P3.697

Positive urine culture as a risk factor for infectious complications following Renal transplant biopsies: A retrospective study

Ludmila Costa (BR)

Bio Abstract

P3.698

HLA antibody screening and persistently elevated background in multiple sera: the implication for histocompatibility and DSA assessment- a case study

Maria Ramirez (AU)

Bio Abstract

P3.700

Transplant Outcomes in Complement-Mediated Kidney Disease: Impact of CFH/CFHR Genetic Variants and Anti–Factor H Antibodies

Nishtha Manuja (IN)

Bio Abstract

P3.701

Knotted stent in transplant kidney – An uncommon complication

Rohit Sethi (AU)

Bio Abstract

P3.702

Spectrum, Clinical Characteristics, and Outcomes of Infections in Renal Allograft Recipients: A Three-Year Prospective Study

Sonia Mahjabin (BD)

Bio Abstract

P3.704

Denosumab for Treatment of Osteoporosis in Kidney Transplant Recipients

Sunny Malde (IN)

Bio Abstract

P3.705

Haemorrhagic cholecystitis during the early post-renal transplant period

Trent Pattenden (AU)

Bio Abstract